Scarica l'app Stockscreener
2.1151
6.00%
-0.1349
C 4 Therapeutics Inc Azioni (CCCC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
10.71%
6.463
|
7.238 | 15.36 | 12.01 | 3.039 |
Operating Expenses
|
3.95%
34.96
|
36.40 | 43.61 | 33.45 | 35.26 |
| Benefits Costs and Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
| Costs And Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
| Operating Income/Loss |
2.27%
-28.50
|
-29.16 | -28.24 | -21.44 | -32.22 |
| Nonoperating Income/Loss |
12.70%
2.481
|
2.842 | 3.578 | 3.726 | 3.858 |
| Income/Loss From Continuing Operations Before Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
|
Net Income/Loss
|
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
| Diluted Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
| Basic Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
| Diluted Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):